Cancer among patients with diabetes, obesity and abnormal blood lipids: A population-based register study in Sweden

Cancer Causes and Control

Volumn 23, Issue 5, 2012, Pages 769-777

  Attner, Bo ^a   Landin Olsson, Mona ^a   Lithman, Thor ^a   Noreen, Dennis ^a   Olsson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Abnormal blood lipids; Cancer; Comorbidity; Diabetes; Epidemiology; Insulin and metformin therapy; Obesity

Indexed keywords

LIPID;

ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERLIPIDEMIA; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; OBESITY; ONSET AGE; OVARY CANCER; PANCREAS CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK FACTOR; SKIN CANCER; STOMACH CANCER; SWEDEN; TREND STUDY; URINARY TRACT CANCER; UTERINE CERVIX CANCER;

AGED; CASE-CONTROL STUDIES; COMMUNITY HEALTH PLANNING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 84862583042     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9946-5     Document Type: Article

References (38)

1. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4-S6
2. Mori M, Saitoh S, Takagi S, Obara F, Ohnishi H, Akasaka H et al (2000) A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer. Asian Pac J Cancer Prev 1(4):269-276
3. Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72-93
4. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674-1685 [Epub 2010/07/01]
5. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103-1123 [Epub 2009/07/22]
6. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829-841 [Epub 2011/03/04]
7. Kritchevsky S (1992) Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12:391-416
8. Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268(1-2):19-24 (Pubitemid 40287822)
9. Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11):2814-2821 [Epub 2009/11/06]
10. Jacobs EJ, Gapstur SM (2009) Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 18(11):2805-2806 [Epub 2009/11/06]
11. Drummond MF, Botten G, Hakkinen U, Pedersen KM (2006) Assessing the quality of Swedish health economics research. Scand J Public Health 34(6):566-570 [Epub 2006/11/3]
12. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27-33 [Epub 2008/09/04]
13. The National Board of Health and Welfare (2008) Cancer incidence in Sweden 2007. Health Dis 11:1-117
14. Huxley R, Ansary-Moghaddam A, de Gonzalez AB, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076-2083 [Epub 2005/05/12] (Pubitemid 40897433)
15. Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2010) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control [Epub 2010/11/26]
16. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2010) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129(7):1708-1717 [Epub 2010/11/26]
17. Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52(9):1755-1765 [Epub 2009/07/16]
18. Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, Selke GW et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52(9):1732-1744 [Epub 2009/07/01]
19. Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52(9):1745-1754 [Epub 2009/07/10]
20. Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C et al (2010) Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 33(9):1997-2003 [Epub 2010/06/17]
21. Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115(2):86-96
22. Schiel R, Beltschikow W, Steiner T, Stein G (2006) Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28(3):169-175 (Pubitemid 43938540)
23. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304-1305 (Pubitemid 40813563)
24. Smith U, Gale EA (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52(9):1699-1708 [Epub 2009/07/15]
25. Siekmeier R, Scheuch G (2008) Inhaled insulin - does it become reality? J Physiol Pharmacol 59(Suppl 6):81-113
26. Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071-1078 (Pubitemid 38918167)
27. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(11):2056-2062 [Epub 2006/11/23] (Pubitemid 44877026)
28. Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169(8):937-945
29. Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124(6):1398-1403
30. Frayling TM, Colhoun H, Florez JC (2008) A genetic link between type 2 diabetes and prostate cancer. Diabetologia 51(10):1757-1760
31. Chu DI, Freedland SJ (2010) Metabolic risk factors in prostate cancer. Cancer [Epub 2010/12/01]
32. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569-578 (Pubitemid 351232031)
33. Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132(6):2208-2225 [Epub 2007/05/15] (Pubitemid 46693749)
34. Ning Y, Wang L, Giovannucci EL (2009) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19-30 [Epub 2009/06/23]
35. Tornberg SA, Holm LE, Carstensen JM (1988) Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27(1):31-37 [Epub 1988/01/01]
36. Vatten LJ, Foss OP (1990) Total serumcholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50(8):2341-2346 [Epub 1990/04/15] (Pubitemid 20134492)
37. Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW (1996) Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 88(1):32-37 [Epub 1996/01/03] (Pubitemid 26006868)
38. Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T et al (2011) Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol 40(6):1667-1677 [Epub 2011/10/11]